Sight Sciences, Inc. (SGHT)

CIK 0001531177 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-05) · 99.1 · 99.2
Q1-2026 8-K (2026-05-06) · 99.1 · 99.2
Latest FY-2025 8-K (2026-03-04) · 99.1 · 99.2  |  8-K (2026-01-13) · 99.1
Q3-2025 8-K (2025-11-06) · 99.1 · 99.2 · 99.3
Q2-2025 8-K (2025-08-07) · 99.1 · 99.2
Q1-2025 8-K (2025-05-08) · 99.1 · 99.2
FY-2024 8-K (2025-03-05) · 99.1 · 99.2  |  8-K (2025-01-14) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1 · 99.2 · 99.3
Q2-2024 8-K (2024-08-01) · 99.1 · 99.2
Q1-2024 —
FY-2023 8-K (2024-03-07) · 99.1 · 99.2
Q3-2023 8-K (2023-11-07) · 99.1 · 99.2

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (unaudited)
—
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Balance Sheet Components
Commitments and Contingencies
Company and Nature of Business
—
Cybersecurity Risk Management, Strategy and Governance
—
Debt
Equity Incentive Plans
Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Net Loss Per Share Attributable To Common Stockholders
Pay Vs Performance Disclosure
Segment Information
Stockholders' Equity
—
Stockholders's Equity
—
Subsequent Events
Summary of Significant Accounting Policies
The Company and Nature of Business
—